尿蛋白定量

  • 网络Urine Protein Quantitation
尿蛋白定量尿蛋白定量
  1. 24h尿蛋白定量明显增高;

    The quantity of the urinary protein in 24 hours was increased significantly .

  2. 观察治疗四周前后24h尿蛋白定量、尿红细胞计数变化。

    After 4 weeks , proteinuria and red blood cell count in urine were measured .

  3. 比较治疗前后24h尿蛋白定量、血浆白蛋白水平。

    Compare the level of plasma albumin and urine protein after the patients were treated .

  4. 流行性出血热患者尿蛋白定量及SDS-PAGE检测的临床意义

    Clinical significance of quantitative analysis and SDS - PAGE of proteinuria in patients with epidemic hemorrhagic fever

  5. 同步观察了患者血肌酐(Cr)、尿素氮(BUN)、肌酐清除率(Ccr)、24小时尿蛋白定量等的变化,按肾功能状态分组统计。

    Creatinine in blood , BUN , clearance of creatinine and urinary protein / 24h were detected in parallel .

  6. 用生化方法测定血糖、血胆固醇、血尿素氮、血肌酐及24小时尿蛋白定量;用RT-PCR和免疫组化方法测定肾组织TGF-β1基因和蛋白水平的表达。

    The levels of blood glucose 、 plasma cholesterol 、 serum BUN 、 serum creatinine and 24 hours proteinuria analysis were measured by biochemistry method .

  7. 方法检测107例不同肾脏疾病患者的24h尿蛋白定量、晨尿尿蛋白/尿肌酐比值和尿蛋白/尿渗透压比值,并进行相关性分析。

    Methods Urine samples of 107 patients with renal diseases were analyzed for 24h urinary protein , protein-osmolality ratio and protein-creatinine ratio .

  8. 治疗组治疗后临床症状评分、24h尿蛋白定量、血BUN明显改善(P<0.05,P<0.01),与对照组比较差异有统计学意义(P<0.05,P<0.01)。

    The clinical symptom score , 24 - h urinary protein and blood urea nitrogen of the two groups have significant differences .

  9. 方法:检测经苦碟子治疗前、后22例糖尿病肾病患者的24h尿蛋白定量、尿微量白蛋白及尿β2-微球蛋白。

    Methods : The changes of urinary protein in 24 hours , urinary microprotein and β _2-M before and after treatment were observed .

  10. 同时测定血浆蛋白C(PC)含量、血常规、血白蛋白、血总蛋白、血脂、部分凝血及纤溶指标、BUN、Cr和24h尿蛋白定量。

    Serum protein C ( PC ), blood routine , albumin , lipid , partial indexes of coagulation and fibrinolysis , BUN , Cr and proteinuria in 24 hours were tested .

  11. 结论:苦芪方治疗糖尿病肾病有较好的临床疗效,并具有减少24h尿蛋白定量、降低尿自蛋白排泄率及改善餐后血糖和脂质代谢等作用。

    Conclusion : KF is effective for DN and can decrease 24h quantitative urinary protein , UAER and improve the blood glucose after meal and metabolism of lipid .

  12. 测定血生化及24h尿蛋白定量,采用特异性抗体和免疫组织化学方法,观察大鼠肾小球血管内皮细胞生长因子及其受体的分布及其强度变化,并结合肾脏病理进行分析;

    Specific antibody and Immunohistochemistry methods were adopted to determine the protein expression of VEGF and its receptor in renal glomeruli , which were analyzed combining with renal pathology .

  13. 观察2组患者用药前后24h尿蛋白定量、1h尿红细胞排泄率、血尿素氮(BUN)、血清肌酐(SCr)及临床疗效。

    24 hours urine protein quantity , 1 hour urine red blood cell excreting rate , blood urea nitrogen and serum creatinine before and after the treatment were observed .

  14. 治疗前后观察D-2聚体、血小板参数、24h尿蛋白定量、白蛋白、胆固醇变化。

    Two groups were measured D-Dimer , platelet parameter , 24h urine protein quantity , serum albumin and cholesterol before and after treatment .

  15. 同时塌陷型患者病程较短,高血压发生率较高,患者血白蛋白水平低,平均24h尿蛋白定量水平较高,肾功能不全的发生率较其它亚型患者高。

    Comparing with other groups , collapsing type has shorter course , higher hypertension rate , more 24h Urine protein and renal inadequacy rate and lower plasma albumin level . 4 .

  16. 罗格列酮能降低大鼠24小时尿蛋白定量、血BUN、Scr,胆固醇,与NX组比有显著差异,(p<0.01,p<0.05)。

    Compared with the NX group , 24 hours urinary protein , BUN , serum creatinine ( SCr ), serum total cholesterol of Rosiglitazone treatment groups rats were substantially decreased , ( p < 0.05 ) .

  17. 治疗组症状改善及尿蛋白定量、尿红细胞、血压、尿白蛋白(ALb)、尿IgG等的降低也较对照组明显。

    In treatment group the reduction of urinary RBC , quantity of urinary protein , blood presure , urinary albumin and urinary IgG were more evident than those in control group .

  18. 两组治疗后24h尿蛋白定量均明显减少,与治疗前相比有显著性差异(P0.01),且治疗组优于对照组(P0.05)。

    Two 24h urine protein after treatment significantly reduced compared with that before treatment there was a significant difference ( P0.01 ), and the treatment group than the control group ( P0.05 ) . 3 .

  19. 观察指标有24h尿蛋白定量、血白蛋白、血肌酐、尿素氮、胆固醇、甘油三酯、肾对白蛋白排泌率、肾组织病理学变化。

    24 hour urine protein excretion rate , serum albumin , plasma creatinine , urea nitrogen , cholesterol , triglyceride , albumin excretion rate and pathological change of renal tissue were observed .

  20. 测定52例单侧肾切除病人的血压、脱酐清除率、24h尿蛋白定量,观察术后不同时间上述指标的变化。52例中,男34例,女18例。

    Creatinine clearance rate ( Ccr ), blood pressurc , and 24h urine protein quantity were determined in 52 patients ( 34 male , 18 female ) who had undergone unilateral nephrectomy operations .

  21. 治疗组在减少24h尿蛋白定量和尿RBC计数方面优于对照组,有统计学差异(P<0.01和P<0.001)。

    The decrease of urinary protein and urinary RBC count in TCM-WM group were better than those in control group , the difference being significantly remarkably ( P < 0.01 and P < 0.001 ) .

  22. 用PCR方法检测ACE基因第16内含子的插入/缺失(insertion/deletion,I/D)多态性,比较血管紧张素转换酶抑制剂治疗前后各基因型患者尿蛋白定量下降程度的差异。

    The ACE gene insertion / deletion ( I / D ) polymorphisms in intron 16 were determined by PCR . A comparison of the reducing urinary protein efficacy of benazepril was made between the patients with different ACE genotypes .

  23. 治疗结果:中西医结合治疗组在降低血沉、24小时尿蛋白定量、提高C3和生活质量方面,均优于西药对照组。

    The result showed that the curative effect of treatment group was better than thot ot cou - trol one in reducing blood sedimentation and urinary protein and improving C3 and vital quality .

  24. 两组尿液指标比较:治疗后,两组24小时尿蛋白定量值均明显下降,与治疗前相比均有显著性差异,且组间比较差异有统计学意义(P0.05)。

    Urine indicators were compared : after treatment , both of the two groups ' s24-hour urinary protein values were significantly decreased and different compared with that before treatment , and the differences between the two groups were statistically significant ( P0.05 ) .

  25. 检测治疗组和对照组治疗前后IL-2、sIL-2R、血浆白蛋白、24小时尿蛋白定量和胆固醇等水平及正常组IL-2、sIL-2R水平。

    The therapy group and the control group were measured IL-2 and sIL-2R and 24h urine protein quantity and serum albumin and cholesterol before and after treatment . The normal group was observed IL-2 and sIL-2R .

  26. 妊高征组血清总蛋白和白蛋白含量明显低于正常对照组,24h尿蛋白定量明显高于正常对照组;

    The levels of blood serum total protein and albumin in patients with PIH were significantly lower than in normal pregnancy . The levels of 24-hour urine proteinuria excretion were significantly lower than in normal pregnancy ;

  27. 每2周观察24h尿蛋白定量、血清白蛋白、尿常规、肝功能、HBV-DNA定量、肾功能、血常规等。

    The course of the treatment was six months . Quantity of the urinary protein , serum albumin , urinary routine , hepatic function and blood routine , et al were observed every 2 weeks .

  28. 结果2组治疗后血浆白蛋白及24h尿蛋白定量均显著改善,而血肌酐、内生肌酐清除率均无明显变化。

    Results After treatment , blood plasma albumin and 24 hours urine protein quantity were both improved significantly in the two groups , while there was no obvious change of serum creatinine and endogenous creatinine clearance rates .

  29. 光镜下观察肾小管间质形态学改变,生物化学方法检测血清肌酐、胆固醇、白蛋白,24h尿蛋白定量,免疫组织化学检测肾组织MMP-9、TIMP-1、型胶原的表达。

    Renal histopathological changes , serum creatinine and cholesterol , urine protein excretion were measured ; the expressions of protein of collagen ⅳ and MMP-9 、 TIMP-1 in the cortex of the kidney were examined utilizing immunohistochemistry .

  30. 从尿蛋白定量,血清总蛋白、白蛋白、白蛋白球蛋白(AG)、血胆固醇及血清肌酐和尿素氮含量的变化情况等方面观察肾复康治疗肾小球肾炎的疗效。

    The effect of Shengfukang ( SFK ) was observed by determining the content of urine protein , serum total protein , serum album ( A ), serum globulin ( G ), A / G , serum cholesterol , serum creatinine , serum urinary nitrogen .